Open-label Study of the Effects of Montelukast in Patients With Chronic Cough

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Montelukast, a leukotriene receptor antagonist, is likely to be effective in the treatment of chronic cough and this could be made objective by measuring cough threshold before and after two weeks of treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Association Asthma, Bulgaria
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• Patients with chronic cough: cough persisting for more than 8 consecutive weeks

Exclusion Criteria:

• Current use of ACE-inhibitors

• Use of systemic steroids in the last 4 weeks

• COPD

• Pregnancy

• Concomitant severe disease

• Smoking